Maleic Acid

Maleic Acid

SCHEMBL8375868

CN(C)C(=O)O.CN(C=C1CC=NC(N)=C1O)C1CCCCC1.O=C(O)/C=C\C(=O)O

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2BTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3MPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PPARGSLC6A2SLC6A3SLC6A4SMOTYK2pol

The experimentally established mechanism targets of Maleic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.30
ADH1C P00326 1/20 0.30
ADH1A P07327 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375152 0.89 ADH1C (0.34) ADH1CADH1A
SCHEMBL8375879 0.76 ITGB1 (0.32) ADH1CADH1A
Dimethylcarbate SCHEMBL8436277 0.64 ADH1C (0.33) ADH1CADH1A
Maleic Acid SCHEMBL8572325 0.62 TRPM8 (0.36) MAPK1
Maleic Acid SCHEMBL9681627 0.62 MEN1 (0.32) MAPK1
SCHEMBL8374737 0.56 RAB9A (0.34) MAPK1
SCHEMBL21891518 0.54 TRPM8 (0.50) ADH1CADH1A
SCHEMBL30764069 0.54 TRPM8 (0.50) ADH1CADH1A
Cyclohexane SCHEMBL5597823 0.53 ALDH1A1 (0.41)
Fumaric Acid SCHEMBL8666586 0.53 HTT (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5869480-A ALLEVIATING MEMORY DYSFUNCTION CHARACTERIZED BY CHOLINERGIC DEFICIT HOECHST MARION ROUSSEL INC. (US) 1999-02-09 US disclosed
US-5866565-A ALZHEIMER'S DISORDERS HOECHST MARION ROUSSEL INC. (US) 1999-02-02 US disclosed